rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROPHARMA Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
1362.05   -23.95   -1.73%
Volume 76,204
Prev close 1,386.00
Day's H/L (Rs.) 1,370.95 - 1,335.00
52wk H/L (Rs.) 1,432.10 - 595.00
Mkt Cap (Rs. Cr) 39,771.86
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
1362.55   3.65   0.27%
Volume 910,477
Prev close 1358.90
Day's H/L (Rs.) 1,372.00 - 1,334.00
52wk H/L (Rs.) 1,432.20 - 591.75
Turnover (Rs. Lacs) 12,347.07
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 2,723 market voices)   

140 Characters
  Cancel
Rom - 2 day(s) ago [SKB] [SKB] Wonderful opportunity in market to know the best stock list to invest by SEBI Registered investment adviser visit http://rediff.ly/3mmdi and register
#Aurobindo-Pharma-Ltd
Reply   |   Share
Rom - 2 day(s) ago [SKB] [SKB] Wonderful opportunity in market to know the best stock list to invest by SEBI Registered investment adviser visit http://rediff.ly/3mmdi and register
#Aurobindo-Pharma-Ltd
Reply   |   Share

Realtime news for Aurobindo Pharma Ltd. (See all 698 news)

24 May 2015, 20:48
Mid-cap pharma shares buck weak sentiment; Aurobindo, Wockhardt up nearly 3% - 5 day(s) ago
Lupin acquires Brazilian pharma company Medquímica Indústria - 14 May 2015
Aurobindo divests stake in Australian subsidiary - 15 Apr 2015
Temasek to invest $151M in Glenmark Pharma - 18 Apr 2015
Plethico to pay Aurobindo $23m to settle Natrol dispute - 10 Apr 2015

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Code of Conduct of Fair Disclosure - 16 May 2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 - 15 May 2015

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
33.87
EPS (Rs.)
40.21
Sales (Rs. Cr)
2,097.99
Face Value (Rs.)
1
Net Profit
Margin (%)
 
16.31
Last Bonus
1:1
Last Dividend(%)
200
Return on
Average Equity
 
29.21

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Ranbaxy Laboratories Ltd.
814.10
Sanofi India Ltd.
3,278.40
Show more companies
Ranbaxy Laboratories Ltd.
814.10
Sanofi India Ltd.
3,278.40
Apollo Hospitals Enterprise Ltd.
1,298.00
Torrent Pharmaceuticals Ltd.
1,242.80
Natco Pharma Ltd.
2,298.35
Dr. Reddy's Laboratories Ltd.
3,620.45
GlaxoSmithKline Pharmaceuticals Ltd.
3,203.95
Cadila Healthcare Ltd.
1,755.55
Alembic Pharmaceuticals Ltd.
555.65
Lupin Ltd.
1,711.55
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close